Carbon Dot-Based Nanoparticles: A Promising Therapeutic Approach for Glioblastoma

Area of Science:

• Nanotechnology
• Materials Science
• Oncology

Background:

• Glioblastoma (GBM) treatment faces challenges including the blood-brain barrier, tumor heterogeneity, and drug resistance.
• Nanotechnology offers potential solutions for targeted drug delivery and overcoming treatment resistance.
• Carbon dots (CDs) are emerging as a novel class of nanoparticles for therapeutic applications.

Purpose of the Study:

• To review the fundamental principles, development, and synthesis of carbon dots (CDs).
• To explore the potential of CDs in glioblastoma (GBM) treatment and other cancer therapies.
• To provide insights into the future research directions for CDs in oncology.

Main Methods:

• Review of existing literature on carbon dots and their applications in cancer therapy.
• Analysis of the properties and synthesis methods of carbon dots (CDs).
• Discussion of various therapeutic strategies involving CDs, including monotherapy and combination therapy.

Main Results:

• Carbon dots (CDs) exhibit high modifiability and functionalization capabilities for targeted drug delivery.
• CDs can be integrated with chemotherapy drugs, genes, immune cells, and photosensitizers.
• CDs demonstrate potential in photodynamic therapy, photothermal therapy, sonodynamic therapy, chemodynamic therapy, and chemotherapy.

Conclusions:

• Carbon dots (CDs) represent a promising nanotherapeutic platform for glioblastoma (GBM) and other cancers.
• CDs offer advantages in targeting tumor cells and reducing systemic toxicity.
• Further research and clinical trials are necessary to translate CD-based therapies into clinical practice.